These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8157047

  • 21. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G, Lennernäs H, Marelli C, Rockich K, Skrtic S.
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [Abstract] [Full Text] [Related]

  • 22. The influence of fluocortolone treatment on the collagen content in guinea pig skin.
    Wepler R, Burkhardt H, Rommel K.
    Arch Dermatol Res (1975); 1977 Jan 31; 257(3):287-92. PubMed ID: 836077
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of fluocortolone in man.
    Legler UF.
    Eur J Clin Pharmacol; 1986 Jan 31; 30(5):615-7. PubMed ID: 3758149
    [Abstract] [Full Text] [Related]

  • 25. Clinical data of fluocortin butylester (FCB) - a new inhalable corticoid.
    Chen-Walden H.
    Z Erkr Atmungsorgane; 1981 Jan 31; 157(3):287-90. PubMed ID: 7340214
    [Abstract] [Full Text] [Related]

  • 26. Partial pharmacodynamic model for the circadian-episodic secretion of cortisol in man.
    Jusko WJ, Slaunwhite WR, Aceto T.
    J Clin Endocrinol Metab; 1975 Feb 31; 40(2):278-89. PubMed ID: 163972
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers.
    Mackie AE, Bye A.
    Clin Pharmacokinet; 2000 Feb 31; 39 Suppl 1():47-54. PubMed ID: 11140433
    [Abstract] [Full Text] [Related]

  • 29. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL, Ludwig EA, Lew KH, Middleton E, Ferry JJ, Jusko WJ.
    Clin Pharmacol Ther; 1996 Mar 31; 59(3):312-21. PubMed ID: 8653994
    [Abstract] [Full Text] [Related]

  • 30. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
    Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R.
    J Investig Med; 2015 Jan 31; 63(1):35-41. PubMed ID: 25386671
    [Abstract] [Full Text] [Related]

  • 31. Adrenocortical responsiveness after discontinuous corticosteroid therapy.
    Beris P, Burger A, Favre L, Riondel A, Miescher PA.
    Klin Wochenschr; 1986 Jan 15; 64(2):70-5. PubMed ID: 3005756
    [Abstract] [Full Text] [Related]

  • 32. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N, Diederich S, Oelkers W.
    Clin Endocrinol (Oxf); 1998 Jan 15; 48(1):45-51. PubMed ID: 9509067
    [Abstract] [Full Text] [Related]

  • 33. Reproducibility of the low dose dexamethasone suppression test: comparison between direct plasma and salivary cortisol assays.
    Reynolds RM, Bendall HE, Whorwood CB, Wood PJ, Walker BR, Phillips DI.
    Clin Endocrinol (Oxf); 1998 Sep 15; 49(3):307-10. PubMed ID: 9861320
    [Abstract] [Full Text] [Related]

  • 34. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M, Elias LL, Elias PC, Moreira AC.
    Clin Endocrinol (Oxf); 2003 Dec 15; 59(6):800-5. PubMed ID: 14974925
    [Abstract] [Full Text] [Related]

  • 35. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S, Van Cauter E, Fang VS, Laderman C, Graybeal ML, Landau RL.
    J Clin Endocrinol Metab; 1985 Mar 15; 60(3):527-35. PubMed ID: 2982900
    [Abstract] [Full Text] [Related]

  • 36. Effect of subanaesthetic ketamine on plasma and saliva cortisol secretion.
    Khalili-Mahani N, Martini CH, Olofsen E, Dahan A, Niesters M.
    Br J Anaesth; 2015 Jul 15; 115(1):68-75. PubMed ID: 25982133
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients.
    Gupta SK, Ritchie JC, Ellinwood EH, Wiedemann K, Holsboer F.
    Eur J Clin Pharmacol; 1992 Jul 15; 43(1):51-5. PubMed ID: 1505609
    [Abstract] [Full Text] [Related]

  • 39. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
    Melin J, Parra-Guillen ZP, Hartung N, Huisinga W, Ross RJ, Whitaker MJ, Kloft C.
    Clin Pharmacokinet; 2018 Apr 15; 57(4):515-527. PubMed ID: 28762136
    [Abstract] [Full Text] [Related]

  • 40. Cortisol secretion in endogenous depression. II. Time-related functions.
    Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS.
    Arch Gen Psychiatry; 1985 Sep 15; 42(9):909-14. PubMed ID: 4037991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.